Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells

Journal of Cellular Biochemistry
Claudio ScafoglioAlessandro Weisz

Abstract

Antiestrogens used for breast cancer (BC) treatment differ among each other for the ability to affect estrogen receptor (ER) activity and thereby inhibit hormone-responsive cell functions and viability. We used high-density cDNA microarrays for a comprehensive definition of the gene pathways affected by 17beta-estradiol (E2), ICI 182,780 (ICI), 4OH-tamoxifen (Tamoxifen), and raloxifene (RAL) in ER-positive ZR-75.1 cells, a suitable model to investigate estrogen and antiestrogen actions in hormone-responsive BC. The expression of 601 genes was significantly affected by E2 in these cells; in silico analysis reveals that 86 among them include one or more potential ER binding site within or near the promoter and that the binding site signatures for E2F-1, NF-Y, and NRF-1 transcription factors are significantly enriched in the promoters of genes induced by estrogen treatment, while those for CAC-binding protein and LF-A1 in those repressed by the hormone, pointing to novel transcriptional effectors of secondary responses to estrogen in BC cells. Interestingly, expression of 176 E2-regulated mRNAs was unaffected by any of the antiestrogens tested, despite the fact that under the same conditions the transcriptional and cell cycle stim...Continue Reading

References

Sep 1, 1978·Cancer Treatment Reviews·H MouridsenL Battersby
Jan 1, 1991·Annual Review of Genetics·H Gronemeyer
May 1, 1989·Journal of Molecular Endocrinology·A E WakelingS W Peters
Nov 11, 1993·International Journal of Cancer. Journal International Du Cancer·X F HuJ R Zalcberg
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R A McClellandR I Nicholson
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V J AssikisI Vergote
Oct 24, 1997·Nature·A M BrzozowskiM Carlquist
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·R M LavinskyD W Rose
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M B EisenD Botstein
Jan 8, 1999·Molecular and Cellular Biochemistry·M A PrattD M Novosad
Dec 1, 1999·Endocrinology·A L WijayaratneD P McDonnell
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A S Levenson, V C Jordan
Apr 5, 2000·The Journal of Biological Chemistry·D A ZajchowskiG M Rubanyi
Aug 18, 2000·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·S KatoJ Yanagisawa
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Sep 5, 2001·The Journal of Biological Chemistry·B S FinlinC M Perou
Oct 3, 2001·Physiological Reviews·S NilssonJ A Gustafsson
Dec 26, 2001·Nucleic Acids Research·Ron EdgarAlex E Lash
Jan 30, 2002·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael Thun
Feb 1, 2002·The New England Journal of Medicine·Christian J GruberJohannes C Huber
Feb 7, 2002·Genomics·Purvesh KhatriStephen A Krawetz
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Elizabeth Barrett-ConnorUNKNOWN MORE Investigators (Multiple Outcomes of Raloxifene Evaluation)
Mar 30, 2002·Science·Benita S Katzenellenbogen, John A Katzenellenbogen
Mar 30, 2002·Science·Yongfeng Shang, Myles Brown
Oct 10, 2002·Journal of Molecular Endocrinology·A InoueS Hayashi
Jan 10, 2003·Nucleic Acids Research·V MatysE Wingender

❮ Previous
Next ❯

Citations

Jun 16, 2010·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Shiva AkhavantabasiAyse E Erson
Mar 2, 2013·Cell Death and Differentiation·D Dolfini, R Mantovani
Oct 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Nandor Gabor ThanDerek E Wildman
Apr 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Maria Dafne CardamoneMichele De Bortoli
Oct 1, 2013·Human Reproduction Update·Gabriela BarrientosSandra M Blois
Jan 26, 2012·Hormones & Cancer·Lorenzo FerraroAlessandro Weisz
Jan 1, 2012·Drug Discovery Today. Disease Mechanisms·Kerrie B BoukerRobert Clarke
Aug 18, 2006·Molecular Aspects of Medicine·Paolo AscenziMaria Marino
Nov 5, 2011·Critical Reviews in Biochemistry and Molecular Biology·Diletta DolfiniRoberto Mantovani
Jan 22, 2013·Maturitas·Gregory T WurzMichael W DeGregorio
Dec 15, 2012·Toxicology·Daniela GentilcoreConcetta Ambrosino
Feb 29, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Maria RavoAlessandro Weisz
Apr 25, 2018·Digestive Diseases and Sciences·Charles J ChoSuhwan Chang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.